Now Hiring: Research Programme Manager, Antimicrobial Resistance Benchmark
Monday, 13 March 2017
Antimicrobial Resistance Benchmark
The Access to Medicine Foundation is looking for an experienced researcher and manager who will lead the research team in charge of producing the Antimicrobial Resistance (AMR) Benchmark, the first-ever tracking tool to assess what pharmaceutical companies are doing to address the problem of AMR.
The Antimicrobial Resistance Benchmark (AMR Benchmark) will guide and incentivise the pharmaceutical industry to do more to address the problem of antimicrobial resistance. The Benchmark will measure and assess the efforts of pharmaceutical companies (from research-based companies to generic medicines manufacturers) in several technical areas, including R&D, access, stewardship, and production.
The AMR Benchmark follows up on one of the recommendations included in the final report of the Review on AMR: “the work of the Access to Medicine Foundation, and its Access to Medicine Index (ATMI), has been effective and widely-influential in shaping how global pharmaceutical companies approach questions of ‘access’ in low and middle-income settings. We believe that that there would be significant value in establishing an iteration of the ATMI specifically for antibiotics, to allow an objective assessment of progress and achievement against these important goals.”
We are looking for a Research Programme Manager to lead the research team in charge of producing the AMR Benchmark. The main responsibilities include:
- Being end-responsible for the production of the AMR Benchmark
- Developing the methodology of the AMR Benchmark through a comprehensive process of multi-stakeholder dialogue and expert consultation
- Ensuring an efficient process of data collection and analysis
- Supervising the research team’s work, and ensuring the excellent quality of its outputs
- Coordinating the work of the ATM Foundation with other initiatives in the AMR field
- Developing and maintaining the relationship of the Foundation with other stakeholders in the AMR field
- Presenting the AMR Benchmark at conferences and external events
- Collaborating efficiently with other staff members, including those in charge of producing the Access to Medicine Index, coordinating the operations of the Foundation and leading the engagement with companies
The Research Programme Manager will report to the Executive Director and eventually to the Director of Research.
The salary will be commensurate to the experience of the candidate.
Profile and essential skills
- A PhD, medical degree, pharmacy degree and evidence of long-term research experience – in health related fields
- At least 3 years work experience with the pharmaceutical industry
- Publications on health-related topics in top-level academic journals and media outlets
- Profound knowledge of infectious diseases and AMR
- At least 5-year experience leading teams and/or managing research projects
- Excellent command of English, both spoken and written (academic and media styles)
- Skilled in both quantitative and qualitative analyses
- Team player, willing to go the extra mile
- Available to start April-May 2017
- A valid work permit to work in the Netherlands is a plus, EU applicants welcome.
Interested candidates should send a CV, two references and two writing samples to Mireille Deen, firstname.lastname@example.org.
Applications will be reviewed on a rolling basis, and interviews will take place in March 2017.
About the Access to Medicine Index
The Access to Medicine Index analyses 20 of the world’s largest research-based pharmaceutical companies with products for high-burden diseases in low- and middle-income countries. The Index ranks these companies according to their efforts to improve access to medicine in seven areas of corporate behaviour, including pricing, patents, ethical behaviour and donations. It covers 107 low- and middle-income countries and 50 high-burden diseases, and examines eight types of products, from medicines to vaccines to diagnostics. The Index identifies best practices, highlights where progress is being made, and uncovers where critical action is still required. In this way, the Index provides both an incentive and a guide for pharmaceutical companies to do more to improve access to medicine. It is published every two years by the Access to Medicine Foundation, an independent non-profit organisation.
About the Access to Medicine Foundation
The Access to Medicine Foundation is an independent, non-profit organisation based in the Netherlands. It aims to advance access to medicine in low- and middle-income countries by stimulating and guiding the pharmaceutical industry to play a greater role in improving access to medicine. The Foundation is funded by the Bill & Melinda Gates Foundation, the Dutch Ministry of Foreign Affairs and the UK Department for International Development. For ten years, the Foundation has been building consensus on the role for the pharmaceutical industry in improving access to medicine and vaccines. It published its first benchmark of industry activity in this area in 2008, in the first Access to Medicine Index. The fifth Access to Medicine Index was published in November 2016. In 2017, the Foundation will publish the first Access to Vaccines Index, funded by the Dutch National Postcode Lottery, and the first Antimicrobial Benchmark, funded by the UK and Dutch governments.